A novel histone deacetylase pathway regulates mitosis by modulating Aurora B kinase activity

  1. Yun Li1,
  2. Gary D. Kao2,
  3. Benjamin A. Garcia3,
  4. Jeffrey Shabanowitz3,
  5. Donald F. Hunt3,4,
  6. Jun Qin5,
  7. Caroline Phelan1, and
  8. Mitchell A. Lazar1,6
  1. 1Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Department of Genetics, and the Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA;
  2. 2Department of Radiation Oncology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA;
  3. 3Department of Chemistry, University of Virginia, Charlottesville, Virginia 22904, USA;
  4. 4Department of Pathology, University of Virginia, Charlottesville, Virginia 22904, USA;
  5. 5Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas 77030, USA

    Abstract

    Histone deacetylase (HDAC) inhibitors perturb the cell cycle and have great potential as anti-cancer agents, but their mechanism of action is not well established. HDACs classically function as repressors of gene expression, tethered to sequence-specific transcription factors. Here we report that HDAC3 is a critical, transcription-independent regulator of mitosis. HDAC3 forms a complex with A-Kinase-Anchoring Proteins AKAP95 and HA95, which are targeted to mitotic chromosomes. Deacetylation of H3 in mitosis requires AKAP95/HA95 and HDAC3 and provides a hypoacetylated H3 tail that is the preferred substrate for Aurora B kinase. Phosphorylation of H3S10 by Aurora B leads to dissociation of HP1 proteins from methylated H3K9 residues on mitotic heterochromatin. This transcription-independent pathway, involving interdependent changes in histone modification and protein association, is required for normal progression through mitosis and is an unexpected target of HDAC inhibitors, a class of drugs currently in clinical trials for treating cancer.

    Keywords

    Footnotes

    | Table of Contents

    Life Science Alliance